Taken together, our study demonstrates abnormal expression levels of oxytocin-related genes in breast cancer tissues versus non-cancerous tissues and influence of cancer on the correlation network between these genes, potentiating these genes as biomarkers for breast cancer. This evidence concerns the gene OXT and cancer.